Evidence map›Paper›PMID 25110546›Full record

ArticleJournal of clinical medicine research2014

Potential biomarker for human uterine leiomyosarcoma.

Takuma Hayashi, Akiko Horiuchi, Hiroyuki Aburatani, Osamu Ishiko, Nobuo Yaegashi, Yae Kanai, Dorit Zharhary, Tanri Shiozawa, Susumu Tonegawa, Ikuo Konishi

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact, top 84% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Takuma HayashiDepartment of Immunology and Infectious Disease, Shinshu University School of Medicine, Matsumoto, Nagano 390-8621, Japan ; Promoting Business Using Advanced Technology, Japan Science and Technology Agency (JST), Chiyoda, Tokyo 102-8666, Japan ; SIGMA-Aldrich Collaboration Laboratory.
Akiko HoriuchiHoriuchi Ladies Clinic, Matsumoto, Nagano 390-0821, Japan.
Hiroyuki AburataniThe Cancer System Laboratory, Research Center for Advanced Science and Technology, The University of Tokyo, Meguro, Tokyo 153-9804, Japan.
Osamu IshikoDepartment of Obstetrics and Gynecology, Osaka City University Graduate School of Medicine, Osaka, Osaka 545-8585, Japan.
Nobuo YaegashiDepartment of Obstetrics and Gynecology, Tohoku University Graduate School of Medicine, Sendai, Miyagi 980-8574, Japan.
Yae KanaiPathology Division, National Cancer Center Research Institute, Chuoku, Tokyo 104-0045, Japan ; The International Human Epigenome Consortium (IHEC) and CREST, Japan Science and Technology Agency (JST), Chiyoda, Tokyo 102-8666, Japan.
Dorit ZharharySIGMA-Aldrich Collaboration Laboratory ; Sigma-Aldrich Israel Ltd, Rehovot 76100, Israel.
Tanri ShiozawaDepartment of Obstetrics and Gynecology, Shinshu University School of Medicine, Matsumoto, Nagano 390-8621, Japan.
Susumu TonegawaPicower Institution and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139-4307, USA.
Ikuo KonishiDepartment of Obstetrics and Gynecology, Kyoto University Graduate School of Medicine, Kyoto, Kyoto 606-8507, Japan.
Shinshu University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID25110546
PMCPMC4125337
OpenAlexW2164088970

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.